GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36507
Submission : 2022-06-16
Status : Active
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36507
Submission : 2022-06-16
Status : Active
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FINISHED DOSAGE FORMULATIONS
Drug : PLAVIX
Dosage Form : TABLET; ORAL
Application Number : 20839
Country : US
Patented : No
Drug : KADIAN
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 20616
Country : US
Patented : No
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 78889
Country : US
Patented : No
Drug : MORPHINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 200812
Country : US
Patented : No
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 216916
Country : US
Patented : No
DEXMETHYLPHENIDATE HYDROCHLORIDE
Drug : DEXMETHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 215523
Country : US
Patented : No

Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 211143
Country : US
Patented : No

Drug : TRAMADOL HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 203494
Country : US
Patented : No

Drug : MEMANTINE HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 203175
Country : US
Patented : No

Drug : DOXYCYCLINE
Dosage Form : TABLET; ORAL
Application Number : 91605
Country : US
Patented : No

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EXCIPIENTS BY APPLICATIONS
MARKET PLACE
Reply
19 Jun 2025
Reply
24 Sep 2024
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]